Market revenue in 2023 | USD 200.0 million |
Market revenue in 2030 | USD 285.4 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 19.45% in 2023. Horizon Databook has segmented the Japan point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is reported to have the largest geriatric population in the world, which can be attributed to increased life expectancy due to medical advancements and reduced fertility rate as a result of post– world war effects.
Moreover, geriatric population is expected to increase in the coming years. According to demographic estimates, about 25% of Japanese population is 65 years and above, which is estimated to rise up to 40% of the country’s population by 2060.
Increasing geriatric population is expected to contribute significantly to rising diabetes burden in the country. In 2019, the number of people suffering from diabetes in Japan reached 9.3 million with aging and obesity being the key causative factors.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Japan point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account